Researchers from the University of Nebraska Medical Center and Wake Forest University are collaborating with San Francisco-based Omada Health to explore the effectiveness of a virtual diabetes prevention program.
The PREDICTS (“Preventing Diabetes with Digital Health and Coaching for Translation and Scalability”) randomized control trial will include approximately 500 participants with verified clinical eligibility for Omada’s CDC-recognized diabetes prevention program, according to an announcement. Omada Health is best known for its digitally-enabled intensive behavioral counseling, enabling individuals at elevated risk of chronic conditions like type 2 diabetes and heart disease to change the habits that put them most at risk, the organization’s officials attest.
Read More: https://www.healthcare-informatics.com/news-item/mobile/healthcare-organizations-partner-study-effectiveness-virtual-diabetes-prevention
What if health care were designed so that in-person visits were the second, third, or even last option for meeting routine patient needs, rather than the first? This question seems to elicit two basic responses — sometimes expressed in the same breath: “The idea will upset many physicians, who are already under duress” and “I wish my health care worked that way.”
Stroke, a leading cause of serious, long-term disability in the United States, ranks as the fifth leading cause of death in South Carolina.
OncoMed Provides 2018 Outlook and 2017 Year-End Cash Balance and Announces an Update on the Rosmantuzumab Program
Year-end 2017 Cash Balance of $103.1 Million
Board of Directors has initiated search to identify successor